BCRX
BCRX
US09058V1035
BioCryst Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 874.837.000 450.712.000
94.1%
Cost of Revenue 19.075.000 12.269.000
55.5%
Gross Profit 855.762.000 438.443.000
95.2%
514.773.000 440.986.000
16.7%
Operating Income 340.989.000 -2.543.000
13508.9%
Pretax Income 267.391.000 -86.954.000
407.5%
Net Income Common Stockholders 263.861.000 -88.881.000
396.9%
-- --
--
-- --
--
ende